Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents

Jean Baptiste Garsi, Sofiane Hocine, Raphaël Hensienne, Matthieu Moitessier, Helen Denton, Louise L. Major, Terry K. Smith*, Stephen Hanessian*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The protozoan parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. are responsible for continued propagation of neglected tropical diseases such as African sleeping sickness, Chagas disease and leishmaniasis respectively. Following a report that captopril targets Leishmania donovani dipeptidyl carboxypeptidase, a series of simple proline amides and captopril analogues were synthesized and found to exhibit 1–2 μM in vitro inhibition and selectivity against Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. The results were corroborated with computational docking studies. Arguably, the synthetic proline amides represent the structurally simplest examples of in vitro pan antiprotozoal compounds.

Original languageEnglish
Article number129883
Number of pages12
JournalBioorganic and Medicinal Chemistry Letters
Volume110
Early online date17 Jul 2024
DOIs
Publication statusPublished - 15 Sept 2024

Keywords

  • Antiprotozoal
  • Captopril surrogates
  • Proline amides
  • ‘Big eye’ phenotype

Fingerprint

Dive into the research topics of 'Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents'. Together they form a unique fingerprint.

Cite this